Inhibrx Biosciences INBX
NASDAQ INBX
$100.32 -4.51 (-4.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Receivables - Other (2023 - 2026)

Updated

Inhibrx Biosciences' Receivables - Other came in at $132,000 for Q2 2026, down 81.9% from $730,000 a year earlier.

Analysis

Inhibrx Biosciences (INBX) Receivables - Other (2023 - 2026) Analysis & Trends

At the end of FY2025, Inhibrx Biosciences' Receivables - Other was $177,000, down 10.2% from FY2024.

  • Going back by year, Receivables - Other was $197,000 in FY2024 (-67.5%) and $607,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Inhibrx Biosciences 1.54 Bn 1.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 727,000.00
Jun 30, 2025 730,000.00
Dec 31, 2024 197,000.00
Jun 30, 2024 952,000.00
Dec 31, 2023 607,000.00
API Access

Inhibrx Biosciences Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=INBX&period=max&api_key=YOUR_API_KEY